Product Releases

New Dissolution Apparatus From Varian, Inc. Enables Testing Of Combinatorial Drug-Device Products

Varian’s new dissolution system is designed to simplify  the testing of drug formulations with extremely low quantities of active ingredients.  The 400-DS meets the compendial  requirements of  a USP Apparatus 7, supports the testing of combinatorial products in which small amounts of drug are combined as part of a medical device such as a stent or implant.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters